# Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic Wounds

> **NCT05619237** · NA · COMPLETED · sponsor: **Chester Ho, MD** · enrollment: 44 (actual)

## Conditions studied

- Pressure Injury
- Venous Leg Ulcer
- Pressure Injury Stage 2
- Pressure Injury Stage III
- Diabetic Foot Ulcer
- Pressure Injury Stage IV
- Leg Ulcer

## Interventions

- **DEVICE:** NanoSALV Catalytic

## Key facts

- **NCT ID:** NCT05619237
- **Lead sponsor:** Chester Ho, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-06
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-05-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-11-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05619237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05619237, "Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic Wounds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05619237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*